Danaher Corporation $DHR Shares Sold by Jackson Square Partners LLC

Jackson Square Partners LLC cut its holdings in Danaher Corporation (NYSE:DHR) by 13.0% during the second quarter, HoldingsChannel reports. The fund owned 14,223 shares of the conglomerate’s stock after selling 2,117 shares during the period. Jackson Square Partners LLC’s holdings in Danaher were worth $2,810,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Red Tortoise LLC grew its holdings in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Ramirez Asset Management Inc. acquired a new position in Danaher in the second quarter valued at about $40,000. Costello Asset Management INC purchased a new position in Danaher during the first quarter worth about $41,000. Mowery & Schoenfeld Wealth Management LLC increased its position in shares of Danaher by 53.8% during the first quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock valued at $42,000 after acquiring an additional 71 shares during the last quarter. Finally, Iron Horse Wealth Management LLC purchased a new stake in shares of Danaher in the 1st quarter valued at approximately $50,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Down 0.4%

NYSE DHR opened at $209.89 on Friday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The firm has a 50 day moving average of $204.02 and a two-hundred day moving average of $200.32. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $148.26 billion, a PE ratio of 43.28, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s dividend payout ratio is currently 26.39%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Barclays increased their price objective on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Robert W. Baird set a $247.00 price objective on Danaher in a research note on Wednesday, October 22nd. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Bank of America lowered their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Finally, Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.